Category - China National Pharmaceutical Group

• Sinopharm has the Rx to realize high-quality developmen­t
• Target set to complete Omicron vaccine trials
• Sinopharm to complete trials of Omicron vaccine in 3 to 4 months
• Sinopharm’s COVID-19 vaccine hailed around globe
• Sinopharm: R&D on vaccine against new variants has begun
• Sinopharm increases COVID vaccine output
• Sinopharm gets OK to test drug for COVID-19
• Kenya OKs Sinopharm vaccine’s use, boosting hope
• Sinopharm unit: Full clinical data submitted
• Sinopharm COVID-19 vaccines appear safe
• Study: Sinopharm shots appear safe, effective
• Efficacy of Sinopharm vaccines tops 70 percent, study finds
• WHO’s Sinopharm approval a big win for global drive
• WHO approval of Sinopharm vaccine welcomed
• China’s Sinopharm vaccine receives WHO emergency approval
• WHO: Emergency use of China’s Sinopharm vaccine is authorized
• Beijing steps up vaccine production
• Vaccine firms ramp up production
• Vaccine companies ramp up to meet demand